To investigate efficacy and safety of clozapine treatment for schizophrenia focusing on plasma clozapine concentrations and cytokine levels.
Not Applicable
Recruiting
- Conditions
- Psychiatric disorder
- Registration Number
- JPRN-UMIN000048075
- Lead Sponsor
- Kosekai-Kusatsu Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
If informed consent is not available.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sequential changes regarding plasma clozapine concentrations and cytokine levels after administration of clozapine
- Secondary Outcome Measures
Name Time Method